Actinium Pharmaceuticals reported $-16.64M in Operating Profit for its fiscal quarter ending in March of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Actinium Pharmaceuticals USD -16.64M 9.13M Mar/2025
Amgen USD 3.96B 464M Dec/2025
Bioline Rx USD -2.21M 96K Sep/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Pfizer USD 4.65B 3.99B Dec/2025